Open Market Through Stock Exchange | ₹210.00 Crores | Listing at BSE, NSE | Tue, Mar 21, 2023 - Fri, May 12, 2023
Natco Pharma Ltd. Buyback is a tender offer for the repurchase of up to equity shares at a buyback price of ₹700 per share with a face value of ₹2 per share, aggregating to ₹210.00 crores.
The buyback opens on Mar 21, 2023 and closes on May 12, 2023.
Dam Capital Advisors Ltd. is the Manager to the Buyback and Venture Capital & Corporate Investments Ltd. is the Registrar and DAM Capital Advisors Limited is the Registered Broker to the Buyback.
Investors are advised to refer to the Natco Pharma Ltd. Letter of Offer for detailed information, including eligibility criteria, entitlement ratio, acceptance methodology, and tax implications.
Offer Opening Date
Tue, Mar 21, 2023
Offer Closing Date
Fri, May 12, 2023
Buyback Price
₹700 per share
Record Date
[.]
| Period Ended | Total Revenue | Profit After Tax | Net Worth |
|---|---|---|---|
| 31-Mar-20 | 2,022.40 | 458.10 | 3,773.50 |
| 31-Mar-21 | 2,155.70 | 442.40 | 4,121.60 |
| 31-Mar-22 | 2,043.80 | 170.00 | 4,263.60 |
| 31-Dec-22 | 1,884.80 | 439.50 | 4,628.20 |
| Amount in ₹ Crore | |||
Incorporated in 1981, Natco Pharma Limited is a vertically integrated and R&D-focused pharmaceutical company. the entity is engaged in developing, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).
Natco Pharma primarily focuses on niche therapeutic areas and complex products. They market and distribute their products in more than 40 countries. Some of the countries where Natco sells its FDF products are the United States, India, and Europe.
Alongside working through direct operations, the company also operates in certain key geographies through its subsidiaries.
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Feb-2023 | 554.95 | 502.00 | 535.04 |
| Jan-2023 | 570.40 | 526.00 | 545.28 |
| Dec-2022 | 599.00 | 548.00 | 565.78 |
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Feb-2023 | 555.00 | 502.00 | 534.88 |
| Jan-2023 | 570.00 | 526.10 | 545.36 |
| Dec-2022 | 600.00 | 547.50 | 565.78 |
The Buyback is being undertaken for the following reasons:
Natco Pharma Ltd.
Natco House Road No.2,
Banjara Hills
Hyderabad-500 034
Hyderabad, Telangana, 500034
Venture Capital & Corporate Investments Ltd.
Lead Manager(s)
Registered Broker
The Natco Pharma Buyback 2023 opens on March 21, 2023, and closes on May 12, 2023.
The Natco Pharma Buyback 2023 is a Open Market Through Stock Exchange.
Natco Pharma Buyback 2023 Schedule
| Buyback Opening Date | March 21, 2023 |
| Buyback Closing Date | May 12, 2023 |
| Last date for acceptance of shares | Upon relevant pay-out by the Stock exchange |
The Natco Pharma Buyback 2023 is being offered at Rs ₹700 per share.
There is no ratio applicable in case of open market offer through stock exchange mechanism.
The Natco Pharma Buyback 2023 has announced a buyback for an aggregate amount of not more than Rs. ₹210.00 Crores with pricing of Rs. ₹700 per share.
The Buyback is being undertaken for the following reasons:
Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.
The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.
The Natco Pharma Buyback 2023 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.
